Your request to link to rcsb for Oxysterols receptor LXR-beta

• 1P8D: x-ray crystal structure of lxr ligand binding domain with 24(s),25- epoxycholesterol (10.1074/JBC.M302260200 )
• 1PQ6: human lxr beta hormone receptor / gw3965 complex (10.1074/JBC.M304842200 )
• 1PQ9: human lxr beta hormone receptor complexed with t0901317 complex (10.1074/JBC.M304842200 )
• 1PQC: human lxr beta hormone receptor complexed with t0901317 (10.1074/JBC.M304842200 )
• 1UPV: crystal structure of the human liver x receptor beta ligand binding domain in complex with a synthetic agonist (10.1016/J.JMB.2003.10.033 )
• 1UPW: crystal structure of the human liver x receptor beta ligand binding domain in complex with a synthetic agonist (10.1016/J.JMB.2003.10.033 )
• 3KFC: complex structure of lxr with an agonist (10.1016/J.BMCL.2009.10.132 )
• 3L0E: x-ray crystal structure of a potent liver x receptor modulator (10.1021/JM901797P )
• 4DK7: crystal structure of lxr ligand binding domain in complex with full agonist 1 (10.1016/J.BMCL.2012.02.028 )
• 4DK8: crystal structure of lxr ligand binding domain in complex with partial agonist 5 (10.1016/J.BMCL.2012.02.028 )
• 4NQA: crystal structure of liganded hrxr-alpha/hlxr-beta heterodimer on dna (10.1038/NSMB.2778 )
• 4RAK: crystal structure of nuclear receptor subfamily 1, group h, member 2 (lxrb) complexed with partial agonist (10.1016/J.BMCL.2014.11.029 )
• 5HJP: identification of lxrbeta selective agonists for the treatment of alzheimer's disease (10.1021/ACS.JMEDCHEM.6B00176 )
• 5I4V: discovery of novel, orally efficacious liver x receptor (lxr) beta agonists (10.1021/ACS.JMEDCHEM.5B02029 )
• 5JY3: crystal structure of lxrbeta (nuclear receptor subfamily 1, group h, member 2) complexed with bms-852927 (10.1021/ACSMEDCHEMLETT.6B00234 )
• 5KYA: brain penetrant liver x receptor (lxr) modulators based on a 2,4,5,6- tetrahydropyrrolo[3,4-c]pyrazole core (10.1016/J.BMCL.2016.08.089 )
• 5KYJ: brain penetrant liver x receptor (lxr) modulators based on a 2,4,5,6- tetrahydropyrrolo[3,4-c]pyrazole core (10.1016/J.BMCL.2016.08.089 )
• 6JIO: human lxr-beta in complex with a ligand (10.1016/J.EJMECH.2019.06.011 )
• 6K9G: human lxr-beta in complex with an agonist (10.1016/J.EJMECH.2020.112240 )
• 6K9H: human lxr-beta in complex with an agonist (10.1016/J.EJMECH.2020.112240 )
• 6K9M: human lxr-beta in complex with an agonist (10.1016/J.EJMECH.2020.112793 )
• 6S4N: lxrbeta ligand binding domain in comlpex with small molecule inhibitors (10.1038/S42003-019-0675-0 )
• 6S4T: lxrbeta ligand binding domain in comlpex with small molecule inhibitors (10.1038/S42003-019-0675-0 )
• 6S4U: lxrbeta ligand binding domain in comlpex with small molecule inhibitors (10.1038/S42003-019-0675-0 )
• 6S5K: lxrbeta ligand binding domain in complex with small molecule inhibitors (10.1038/S42003-019-0675-0 )